Benjamin Esterni
- Hematology top 1%
- Acute Myeloid Leukemia Research 14
- Hematopoietic Stem Cell Transplantation 11
- Oncology top 1%
- Cancer Treatment and Pharmacology 10
- Colorectal Cancer Treatments and Studies 9
- HER2/EGFR in Cancer Research 8
- Cancer Research top 2%
- Breast Cancer Treatment Studies 11
- Genetics top 2%
-
- Acute Lymphoblastic Leukemia research 9
-
- Prostate Cancer Treatment and Research 8
- Co-authors
- Daniel BirnbaumPatrice ViensFrançois BertucciPascal FinettiJocelyne JacquemierNathalie CerveraEmmanuelle Charafe‐JauffretLuc Xerri
- Cited by
- HematologyOncologyCancer Research
- Journals
- Journal of Clinical Oncology (11 papers)Blood (7 papers)Bone Marrow Transplantation (6 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Benjamin Esterni
74 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Hematology 1.0k
- Oncology 2.2k
- Cancer Research 1.0k
- Genetics 422
- Pathology and Forensic Medicine 489
Countries citing papers authored by Benjamin Esterni
This map shows the geographic impact of Benjamin Esterni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Esterni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Esterni more than expected).
Fields of papers citing papers by Benjamin Esterni
This network shows the impact of papers produced by Benjamin Esterni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Esterni. The network helps show where Benjamin Esterni may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Benjamin Esterni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 26 | |
| 2 | 2013 | 65 | |
| 3 | Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: response, survival and prognostic factors. | 2011 | 15 |
| 4 | 2011 | 35 | |
| 5 | 2010 | 210 | |
| 6 | 2010 | 17 | |
| 7 | 2010 | 12 | |
| 8 | 2010 | 14 | |
| 9 | 2010 | 93 | |
| 10 | Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancerbreakdown → | 2009 | 575 |
| 11 | 2009 | 122 | |
| 12 | 2009 | 69 | |
| 13 | 2009 | 6 | |
| 14 | 2008 | 28 | |
| 15 | 2007 | 15 | |
| 16 | 2007 | 130 | |
| 17 | 2006 | 107 | |
| 18 | 2006 | 19 | |
| 19 | 2005 | 11 | |
| 20 | 2005 | 42 |
About Benjamin Esterni
Benjamin Esterni is a scholar working on Hematology, Oncology and Cancer Research, having authored 75 papers that have together received 4.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (14 papers), Hematopoietic Stem Cell Transplantation (11 papers), Breast Cancer Treatment Studies (11 papers), Cancer Treatment and Pharmacology (10 papers), Colorectal Cancer Treatments and Studies (9 papers), Acute Lymphoblastic Leukemia research (9 papers), HER2/EGFR in Cancer Research (8 papers) and Prostate Cancer Treatment and Research (8 papers). The work is most often cited by research in Hematology (1.0k citations), Oncology (2.2k citations) and Cancer Research (1.0k citations). Benjamin Esterni has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Daniel Birnbaum, Patrice Viens, François Bertucci, Pascal Finetti, Jocelyne Jacquemier, Nathalie Cervera, Emmanuelle Charafe‐Jauffret, Luc Xerri, Norbert Vey and Christian Chabannon. Their work appears in journals such as Journal of Clinical Oncology, Blood, Bone Marrow Transplantation, Breast Cancer Research and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.